Genovis AB, a leading provider of innovative enzyme technologies, today announced it has received an order with a total value of approximately EUR 1 million (SEK 11 million) from a global pharmaceutical company. The order includes material and related services connected to one of Genovis’ proprietary antibody conjugation technology platforms. Genovis’ technology platform will be […]
BOSTON — 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the United States Marine Corps CBRNE Installation and Protection Program purchased 17 of the company’s XplorIR devices for the chemical identification and quantification of hazardous gases and vapors. The program’s mission is to support federal firefighters, military police, post offices […]
More than 1,000 Korean genomes to be sequenced for global reference standards, advancing disease research and precision medicine MENLO PARK, Calif. and SEOUL, South Korea — PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its HiFi sequencing technology has been selected as the primary platform for the Korean Pangenome […]
The license will provide Sanofi scientists worldwide access to BenchSci’s ASCEND platform, which aims to accelerate drug discovery across multiple therapeutic areas. TORONTO—BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced a three-year agreement with Sanofi to deploy and use BenchSci’s ASCEND™ platform across Sanofi’s global preclinical research organization. […]
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate long-read sequencing solutions, today announced that the National Institute on Aging’s Long Life Family Study (LLFS) […]
BILLERICA, Mass.– Bruker Corporation (Nasdaq: BRKR) today announced new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation from the New York Structural Biology Center (NYSBC), the University of Delaware and Northwestern University. Supported by the National Institutes of Health (NIH) and the National Science Foundation (NSF), these high-performance systems will enable leading research teams to […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ System, a flagship instrument for single-cell multiomics analysis, at Addenbrooke’s Hospital of the University of Cambridge, United Kingdom. Together with its comprehensive menu of assays for DNA, RNA, and protein […]
BOSTON — Volta Labs today announced that the Prinses Máxima Center for Pediatric Oncology has acquired the Callisto(TM) platform to streamline sample preparation across multiple genomics workflows, supporting both Illumina and Oxford Nanopore Technologies (ONT) sequencing platforms. The Prinses Máxima Center is the largest pediatric cancer center in Europe, dedicated to integrating care and research […]
SANTA CLARA, Calif. and MILAN, Italy – Picarro Inc., a global leader in methane emission management and reduction solutions, today announced that Italgas, following its recent acquisition of 2i Rete Gas, will extend the deployment of Picarro’s Network Intelligence technology and solutions to cover its newly expanded infrastructure. Italgas now serves approximately 13 million customers with more than 150,000 […]
Phase II award focuses on ruggedizing BioFlyte’s BioTOF technology for deployment on unmanned ground vehicles, enabling mobile chem/biothreat detection in expeditionary environments ALBUQUERQUE, N.M. — BioFlyte, a chemical and bioaerosol surveillance firm with a disruptive new class of fieldable chemical and biological threat collection, detection, and identification solutions, today announced it has been awarded a […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
